Galen completes femhrt acquisition

Pharmaceuticals business Galen Holdings has completed the acquisition of femhrt, the hormone replacement therapy.

Galen completes femhrt acquisition

Pharmaceuticals business Galen Holdings has completed the acquisition of femhrt, the hormone replacement therapy.

Galen bought the rights to femhrt from Pfizer.

You have reached your article limit. Already a subscriber? Sign in

Continue reading for €5

Unlock unlimited access and exclusive benefits

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited